Great news for Uganda: US donates an initial $2bn for COVAX Vaccine program

- Advertisement -

Thanks to the Congress and the generosity of the American people, President Biden announced that the United States intends to provide an initial $2 billion, out of a total planned $4 billion, to Gavi, the Vaccine Alliance, to support the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC) to provide COVID-19 vaccines for 92 low- and middle-income countries. Together, this group of 172 countries represents more than 70% of the world’s population
Uganda submitted a COVAX application on December 7 under the Covax facility where we shall be able to access approximately nine million doses of the vaccine to cover 20 per cent of the population

COVAX Facility aims to provide access to almost 2.3 billion doses of vaccines this year. COVAX Facility gives each country its best chance at protecting the most vulnerable members of their populations – which in turn gives the world its best chance at mitigating the toll this pandemic has taken on individuals, communities and the global economy.
Through the U.S. Agency for International Development, this contribution will support the purchase and delivery of safe and effective COVID-19 vaccines for the world’s most vulnerable and at-risk populations, including frontline health care workers.
This support is critical to controlling the pandemic and slowing the emergence of new variants as well as helping restart the global economy, all of which will ultimately benefit the American people.

- Advertisement -

The U.S. government will provide additional funding through 2022 and will work with other donors to make further pledges and commitments to meet the critical needs of the Gavi COVAX AMC.
The Biden-Harris Administration has made it clear that our goal is to vaccinate vulnerable populations and reach those without other options, while working with our partners and governments around the world to ensure that none of us are in this alone.

- Advertisement -


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.